Medication utilization and adherence in a health savings account-eligible plan

American Journal of Managed Care

Volumn 19, Issue 12, 2013, Pages

  Fronstin, Paul ^a   Sepulveda, Martin J ^b   Roebuck, M Christopher ^c  

^a Employee Benefit Research Institute   (United States)

^b IBM   (United States)

^c RxEconomics LLC (MCR)   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRESCRIPTION DRUG;

ADULT; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DEPRESSION; DIABETES MELLITUS; DRUG UTILIZATION; DYSLIPIDEMIA; EMPLOYER; FEMALE; HEALTH INSURANCE; HUMAN; HYPERTENSION; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; PREFERRED PROVIDER ORGANIZATION; PRESCRIPTION; PRIORITY JOURNAL; CASE CONTROL STUDY; CHRONIC DISEASE; COST; ECONOMICS; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ADULT; CASE-CONTROL STUDIES; CHRONIC DISEASE; DRUG PRESCRIPTIONS; FEMALE; HEALTH BENEFIT PLANS, EMPLOYEE; HUMANS; MALE; MEDICAL SAVINGS ACCOUNTS; MEDICATION ADHERENCE; MIDDLE AGED; UNITED STATES;

EID: 84892408732     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Centers for Disease Control and Prevention. Chronic diseases and health promotion. http://www.cdc.gov/chronicdisease/overview/index.htm. Updated August 13, 2012. Accessed October 29, 2012.
2. Centers for Medicare & Medicaid Services. National Health Expenditures: Tables 1-23. http://www.cms.gov/Research-Statistics-Data-and- Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/Downloads/tables. pdf. Accessed October 29, 2012.
3. Lichtenberg FR. Effects of new drugs on overall health spending: Frank Lichtenberg responds. Health Aff (Millwood). 2007;26(3):887-890.
4. Stuart BC, Doshi JA, Terza JV. Assessing the impact of drug use on hospital costs. Health Serv Res. 2009;44(1):128-144.
5. Roebuck MC, Liberman JN, Gemmill-Toyama M, Brennan TA. Medication adherence leads to lower health care use and costs despite increased drug spending. Health Aff (Millwood). 2011;30(1):91-99.
6. World Health Organization. Adherence to Long-Term Therapies: Evidence for Action. http://www.who.int/chp/knowledge/publications/adherence-report/en/ index.html. Published 2003. Accessed October 29, 2012.
7. Fischer MA, Choudhry NK, Brill G, et al. Trouble getting started: predictors of primary medication nonadherence. Am J Med. 2011;124(11): 1081.e9-e22.
8. Karter AJ, Parker MM, Moffet HH, Ahmed AT, Schmittdiel JA, Selby JV. New prescription medication gaps: a comprehensive measure of adherence to new prescriptions. Health Serv Res. 2009;44(5, pt 1): 1640-1661.
9. Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA. 2002;288(4):462-467.
10. Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA. 2002;288(4):455-461.
11. Yeaw J, Benner JS, Walt JG, Sian S, Smith DB. Comparing adherence and persistence across 6 chronic medication classes. J Manage Care Pharm. 2009;15(9):724-736.
12. Viswanathan M, Golin CE, Jones CD, et al. Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review. Ann Intern Med.2012;157(11):785-795.
13. Chernew ME, Juster IA, Shah M, et al. Evidence that value-based insurance can be effective. Health Aff (Millwood). 2010;29(3):530-536.
14. Bosworth HB, Duke University Medical Center, National Consumers League. Medication Adherence: Making the Case for Increased Awareness. http://scriptyourfuture.org/wp-content/themes/cons/m/Script-Your-Future- Briefing-Paper.pdf. Published 2011. Accessed October 29, 2012.
15. Kaiser Family Foundation, Health Research & Educational Trust, NORC at the University of Chicago. Employer Health Benefits: 2011 Annual Survey. http://kaiserfamilyfoundation.files.wordpress.com/2013/04/8225.pdf. Published 2011. Accessed October 29, 2012.
16. Fronstin P. Findings from the 2011 EBRI/MGA Consumer Engagement in Health Care Survey. EBRI Issue Brief. 2011(365):1-26.
17. Buck K; America's Health Insurance Plans, Center for Policy and Research. January 2012 Census shows 13.5 Million People Covered by Health Savings Account/High-Deductible Health Plans (HSA/HDHPs). http://www.ahip.org/HSA2012/. Published May 2012. Accessed October 29, 2012.
18. Towers Watson/National Business Group on Health. Performance in an Era of Uncertainty: 17th Annual Employer Survey on Purchasing Value in Health Care. http://www.towerswatson.com/downloadmedia.aspx?media={AEFCOB68B2BA-4261-8E24- 36E2FDE2915D}. Accessed October 29, 2012.
19. Beeuwkes Buntin M, Haviland AM, McDevitt R, Sood N. Healthcare spending and preventive care in high-deductible and consumer-directed health plans. Am J Manag Care. 2011;17(3):222-230.
20. Lo Sasso AT, Helmchen LA, Kaetner R. The effects of consumerdirected health plans on health care spending. J Risk Insurance. 2010;77(1):85-103.
21. Lo Sasso AT, Shah M, Frogner BK. Health savings accounts and health care spending. Health Serv Res. 2010;45(4):1041-1060.
22. Parente ST, Feldman R, Christianson JB. Evaluation of the effect of a consumer-directed health plan on medical care expenditures and utilization. Health Serv Res. 2004;39(4):1189-1209.
23. Feldman R, Parente ST, Christianson JB. Consumer-directed health plans: new evidence on spending and utilization. Inquiry. 2007;44(1): 26-40.
24. Parente ST, Feldman R, Chen S. Effects of a consumer-driven health lan on pharmaceutical spending and utilization. Health Serv Res. 2008;43(5, pt 1):1542-1556.
25. Fairman K, Sundar H, Cox E. What Happens to Prescription-Drug Use After Consumer-Directed Health Plan Enrollment? Express-Scripts Report No. 07-05235, 2007. Accessed October 29, 2012.
26. Haviland AM, Sood N, McDevitt RD, Marquis MS. The effects of consumer-directed health plans on episodes of health care. Forum Health Econ Policy. 2011;14(2):1-27.
27. Charlton ME, Levy BT, High RR, Schneider JE, Brooks JM. Effects of health savings account-eligible plans on utilization and expenditures. Am J Manag Care. 2011;17(1):79-86.
28. Greene J, Hibbard J, Murray JF, Teutsch JM, Berger ML. The impact of consumer-directed health plans on prescription drug use. Health Aff (Millwood). 2008;27(4):1111-1119.
29. Chen S, Levin RA, Gartner JA. Medication adherence and enrollment in a consumer-driven health plan. Am J Manag Care. 2010;16(2): e43-e50.
30. Freid VM, Bernstein AB, Bush MA. Multiple chronic conditions among adults aged 45 and over: trends over the past 10 years. NCHS Data Brief. 2012;(100):1-8.
31. Iacus SM, King G, Porro G. Causal inference without balance checking: coarsened exact matching. Political Analysis. 2011;20(1):1-24.
32. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383.
33. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for definingcomorbidities in ICD-9-CM And ICD-10 administrative data. Med Care. 2005;43(11):1130-1139.
34. Pharmacy Quality Alliance. http://www.pqaalliance.org/measures/cms.asp.
35. Stata [computer program]. Release MP 12.1. College Station, TX: StataCorp LP; 2012.
36. Newhouse J; Insurance Experiment Group. Free for All? Lessons From the RAND Health Insurance Experiment. Cambridge, MA: Harvard University Press; 1993.
37. Carls GS, Roebuck MC, Brennan TA, Slezak JA, Matlin OS, Gibson TB. Impact of medication adherence on absenteeism and short-term disability for five chronic diseases. J Occup Environ Med. 2012;54(7): 792-805.
38. Gehi A, Haas D, Pipkin S, Whooley MA. Depression and medication adherence in outpatients with coronary heart disease: findings from the heart and soul study. Arch Intern Med. 2005;165(21):2508-2513.